LTA4H
MOLECULAR TARGETleukotriene A4 hydrolase
LTA4H (leukotriene A4 hydrolase) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting LTA4H
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | ubenimex | 4.57 | 96 |
| 2 | shogaol | 3.47 | 31 |
| 3 | kelatorphan | 1.95 | 6 |
| 4 | Leukotriene A4 (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. | 1.10 | 2 |
| 5 | scriptaid | 0.69 | 1 |
About LTA4H as a Drug Target
LTA4H (leukotriene A4 hydrolase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented LTA4H interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
LTA4H inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.